Redpill, appreciate the link. Lots of new information to review....

Redpill, appreciate the link. Lots of new information to review.

New COO will have quite substantial contacts and know the industry inside and out one would believe.

Also:
Although legislation exists, reported needlestick injuries remain stable. Unilife believes one key
reason is that the current generation of safety syringes does not meet the functional and safety
requirements of healthcare workers. These devices may instead put workers at an increased risk of
infection from needlesticks or splatter due to an incorrect use or non-activation of safety mechanisms.

What is the comparative costs of current needles used. Is there a cost motivation to switch over?

The fact that SA still do have an exclusivity agreement with UNS is most definatly a speed bump to other parties being involved.

UNS seem to require reg approval of its finalised product from its manufacturing facility, as well as SA requiring FDA approval for the prefilled product. I could not see SA announcing anything major with UNS until such approval has been granted.